ctrl K

Watchlist Price Alert

Reviva Pharmaceuticals I... (RVPH)

NASDAQ: RVPH · Real-Time Price · USD

0.84

0.00 (0.12%)

At close: May 16, 2025, 3:58 PM

0.82

-1.81%

Pre-market: May 19, 2025, 04:18 AM EDT

Reviva Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Feb 29, 2020	Feb 28, 2019
Cash & Equivalents	13.48M	23.37M	18.52M	29.69M	8.76M	193.00	n/a
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	65.24M	65.24M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	819.72K	n/a	n/a	n/a	1.82K	1.82K	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	666.43K	332.93K	403.82K	1.72M	69.58K	n/a	n/a
Total Current Assets	14.68M	23.7M	18.92M	31.4M	8.76M	193.00	65.24M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	591.00	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	819.72K	n/a	n/a	n/a	1.82K	2.41K	n/a
Total Assets	15.5M	23.7M	18.92M	31.4M	8.76M	2.6K	65.24M
Account Payables	6.28M	3.85M	3.52M	509.58K	1.01M	224.54K	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	2.72M	n/a
Short-Term Debt	458.15K	n/a	n/a	n/a	n/a	3.77M	n/a
Other Current Liabilities	635.59K	400.49K	2.52M	1.84M	324.7K	101.53K	n/a
Total Current Liabilities	14.6M	17.18M	6.04M	2.34M	1.33M	6.81M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	89.01K	806.65K	567.44K	372.73K	2.96M	n/a	n/a
Total Long-Term Liabilities	89.01K	806.65K	567.44K	372.73K	2.96M	n/a	n/a
Total Liabilities	14.69M	17.98M	6.61M	2.72M	1.33M	6.81M	6.09M
Total Debt	458.15K	n/a	n/a	n/a	n/a	3.77M	n/a
Common Stock	4.66K	2.79K	2.04K	1.44K	923.00	618.00	n/a
Retained Earnings	-164.27M	-134.35M	-91.17M	-66.83M	-58.31M	-54.53M	n/a
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	-54.53M	n/a
Shareholders Equity	812.57K	5.72M	12.32M	28.69M	7.43M	-6.81M	n/a
Total Investments	n/a	n/a	n/a	n/a	n/a	65.24M	65.24M